Apoptosis and gastric carcinogenesis: Immunohistochemical analysis of Bax and Bcl-2 proteins

Annals of Gastroenterology

Volumn 20, Issue 2, 2007, Pages 124-129

  Chatzipantelis, Paschalis ^a,b,c   Konstantinou, P ^a   Voros, D ^a   Smyrniotis, V ^a   Kondi Pafiti, Agatha ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Apoptosis; Bax; Bcl 2; Gastric carcinogenesis

Indexed keywords

EOSIN; HEMATOXYLIN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; ATROPHIC GASTRITIS; CHRONIC GASTRITIS; CONTROLLED STUDY; DYSPLASIA; FEMALE; GENE REPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS;

EID: 34548522188     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992; 52: 6735-6740.
2. Kerr JFR, Myllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
3. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonu-clease activation. Nature 1980; 284: 555-556.
4. Wyllie AH, Morris AL, Smith AL, Dunlop D. Chromaton cleavage in apoptosis: associated with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
5. Williams GT. Programmed cell death and oncogenesis. Cell 1991; 65: 1097-1098.
6. Antonsson B. Bax and other pro-apoptotic Bcl-2 family killer-proteins and their victim, the mitochondrion. Cell Tissue Res 2001; 306: 347-361.
7. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
8. El-Rifai W, Powell SM. Molecular biology of gastric cancer. Semin Radiat Oncol 2002; 12: 128-140.
9. Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science 1984; 226: 1097-1099.
10. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 2001; 6: 209-222.
11. Rugge M, Correa P, Dixon MF et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24: 167-176.
12. World Health Organisation. Classification of Tumors of the Digestive System. Hamilton S, Aaltonen R, (eds). Lyon, IARC Press, 2000, p.38.
13. Koshida Y, Saegusa M, Okayasu I. Apoptosis cell proliferation and expression of bcl-2 and bax in gastric carcinomas: immunohistochemical and clinicopathological study. Br J Cancer 1997; 75: 367-373.
14. Ishida M, Gomyo Y, Tatebe S, Ohfuji S, Ito H. Apoptosis in human gastric mucosa, chronic gastritis, dysplasia, and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Virchows Arch 1996; 428: 229-235.
15. Mijic A, Ferencic Z, Belicza M, Facic A, Scvic SR, Sarceric B. Apoptosis in human gastric polyps and adenocarcinomas: a stereological analysis. Hepatogastroenterology 1998; 45: 684-690.
16. Xu AG, Li SG, Liu JH, Gan AH. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol 2001; 7: 403-406.
17. Krajewski S, Blomqvist C, Frarssilla K, Krajewska M, Wasenivs VM, Niskanen E. Reduced expression of pro-apoptosis gene Bax is associated with poor response rates to combination chemotherapy and adenocarcinoma. Cancer Res 1995; 55: 4471-4478.
18. Chresta CM, Masters JRW, Hickman JA. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with ganetional p53 and a high Bax, Bcl-2 ratio. Cancer Res 1996; 56:1834-1841.
19. Krajewska M, Moss SF, Krajewski S, Song K, Holt PK, Reed JC. Elevated expression of Bcl-x and reduced Bax in primary colorectal adenocarcinomas. Cancer Res 1996; 58:2422-2427.
20. Krajewski M, Krajewski S, Epstein JL Reed JC, Franssila K. Immunohistochemical analysis of Bcl-2, Bax, Bcl-x and mel-1 expression in prostate cancers. Am J Pathol. 1996; 148:1567-1576.
21. Pollina L, Pacini F, Fontanini G, Vignati S, Bevilacqua G, Basolo F. bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. Br J Cancer 1996; 73:139-143.
22. Manne U, Myers RB, Moron C, et al. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 1997; 74:346-358.
23. Móller W, Schneiders A, Hommel G, Gabbert H. Prognostic value of bcl-2 expression in gastric cancer. Anticancer Res 1998; 18:4699-4704.
24. Scopa CD, Vagianos C, Kardamakis D, et al. Bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal carcer. Appl Immunohistochem Mol Morphol 2001; 9:329-334.
25. Nakamura T, Nomura S, Skai T. Expression of bcl-2 onco-protein in gastrointestinal and uterine carcinomas and their precursor lesions. Hum Pathol 1997; 28:309-315.
26. Cho J-H, Kim WH. Altered topographic expression of p21/WAF1/CIP1/SDI1, bcl-2 and p-53 during gastric carcinogenesis. Pathol Res Pract 1998; 194:309-317.
27. Krajewska M, Fenoglio-Preiser CM, Krajewski S; et al. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol 1996; 149:1449-1457.
28. Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 1995; 75:2209-2213.
29. Maeda S, Yoshida H, Mitsumo Y, et al. Analysis of apoptotic and anti-apoptotic signalling pathways induced by Helicobacter pylori. Gut 2002; 50:771-778.
30. Liu HF, Liu WW, Wang GA, Teng XC. Effect of Helicobacter pylori infection on Bax protein expression in patients with gastric precancerous lesions.